Bulletin
Investor Alert

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Apr 16, 2021, 4:19 p.m.

/zigman2/quotes/203973516/composite

$

418.55

Change

0.00 0.00%

Volume

Volume 64,110

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Previous close

$ 415.18

$ 418.55

Change

+3.37 +0.81%

Day low

Day high

$412.05

$419.78

Open

52 week low

52 week high

$200.09

$423.09

Open

Robert V. Baumgartner

Mr. Baumgartner is Chairman and CEO, Center for Diagnostic Imaging. CDI is a leading provider of diagnostic imaging services. Prior to joining CDI, Mr. Baumgartner held positions of CEO and Director of American Coating International, President and CEO of First Solar, President of Apogee Auto Glass Group, and other executive positions.

Mr. Baumgartner holds a BBA from Notre Dame and is a CPA. He is also an Advisory Board Member with North Peak Capital.

Transactions

Date Shares Transaction Value
11/18/2020 5,000   Disposition at $303.34 per share. 1,516,700
11/18/2020 5,000   Derivative/Non-derivative trans. at $66.9 per share. 334,500
10/29/2020 391   Award at $0 per share. 0
05/21/2020 125   Disposition at $267.94 per share. 33,493
05/21/2020 1,974   Disposition at $267.32 per share. 527,690
05/21/2020 1,601   Disposition at $266.07 per share. 425,979
05/21/2020 1,300   Disposition at $265.35 per share. 344,955
05/21/2020 5,000   Derivative/Non-derivative trans. at $70.35 per share. 351,750
10/24/2019 495   Award at $0 per share. 0
08/07/2019 500   Acquisition at $191.06 per share. 95,530
10/25/2018 514   Award at $0 per share. 0
08/24/2018 5,000   Disposition at $188.47 per share. 942,350
08/24/2018 5,000   Derivative/Non-derivative trans. at $61.46 per share. 307,300
11/01/2017 5,000   Disposition at $130.18 per share. 650,900
11/01/2017 5,000   Derivative/Non-derivative trans. at $63.03 per share. 315,150
10/26/2017 739   Award at $0 per share. 0
10/27/2016 914   Award at $0 per share. 0
09/02/2016 2,613   Disposition at $107.15 per share. 279,983
09/02/2016 2,613   Derivative/Non-derivative trans. at $65.47 per share. 171,073
09/01/2016 3,854   Disposition at $107.18 per share. 413,072
09/01/2016 1,467   Derivative/Non-derivative trans. at $66.59 per share. 97,687
09/01/2016 2,387   Derivative/Non-derivative trans. at $65.47 per share. 156,276
08/24/2016 3,533   Disposition at $107.1 per share. 378,385
08/24/2016 3,533   Derivative/Non-derivative trans. at $66.59 per share. 235,262

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Senior Director-Investor Relations
Mr. Struan Robertson
Vice President–Human Resources
Mr. Robert V. Baumgartner
Chairman
Dr. Rupert J. Vessey
Independent Director
Ms. Julie L. Bushman
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna H. Seth
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.